Royal HaskoningDHV has, following an internal and external search, appointed Nynke Dalstra as Chief Financial Officer. Dalstra already held the role on an interim basis and replaces former holder, Jaska de Bakker.
Nynke Dalstra joined Royal Haskoning in 2009, where she worked as a Group Controller until 2011 when she was promoted to Finance Director. Following the merger between Royal Haskoning and DHV in 2012, she became a Finance Director at the new entity. She previously worked for Group Controller for brachytherapy (radiation therapy) provider Nucletron. Earlier in her career she worked at Akzo Nobel, rising to the role of Controller, primarily in the firm’s gas/electricity business, during her more than 12 year at the company.
Dalstra holds a Master’s degree in Mechanical Engineering from the University of Twente.
Dalstra has been the interim Chief Financial Officer at Royal HaskoningDHV since October, following the departure of Jaska de Bakker. Dalstra takes responsibility for the firm’s finances, as well as taking up a key Executive Board position next to CEO Erik Oostwegel.
Joop van Oosten, Chairman of the Supervisory Board says, that, following an internal and external search for a new CFO it was concluded that Dalstra was the best candidate. Adding, “She is talented, knows our company and our markets and has excellent leadership skills. In combination with the passion for her work and the good match with CEO Erik Oostwegel and the Executive Council we think the company’s leadership is in good hands.”